Status:
TERMINATED
NICU-TECH RM9L-RS Probe ME Feasibility Study
Lead Sponsor:
GE Healthcare
Conditions:
Neonates
Eligibility:
All Genders
23-6 years
Brief Summary
Use of a new ultrasound device designed for babies to look at the catheters in veins and arteries as well as the blood vessel itself. An observational study to assess the the clinicians perception of ...
Detailed Description
The intent of the study is to confirm the maximum penetration of the NICU-Tech RM9L-RS probe. The investigators collected images on patients with PIV (Peripheral Intra Venous)/PAC (Peripheral Arterial...
Eligibility Criteria
Inclusion
- Neonates that are 23 gestational weeks at birth (and greater than 500 grams) to a 6 month old born infant at term (maximum weight 7 kg) who already have one or more lines placed (PIV/PAC/UVC/UACs/PICC) as part of their medical care. NO INFANT WILL HAVE A LINE PLACE FOR THE PURPOSE OF THIS STUDY
Exclusion
- Neonates that are less than 23 gestational weeks at birth
- Neonates that are 23 gestational weeks at birth but are less than 500 grams in weight
- Patients weighing more than 7 kg.-Patients older than 6 months
Key Trial Info
Start Date :
June 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2011
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT01181596
Start Date
June 1 2010
End Date
November 1 2011
Last Update
August 6 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCSD Medical Center
San Diego, California, United States, 92103